SK284731B6 - Indazolamidová zlúčenina, spôsob jej prípravy, medziprodukt na jej prípravu a farmaceutický prostriedok s jej obsahom - Google Patents

Indazolamidová zlúčenina, spôsob jej prípravy, medziprodukt na jej prípravu a farmaceutický prostriedok s jej obsahom Download PDF

Info

Publication number
SK284731B6
SK284731B6 SK1423-99A SK142399A SK284731B6 SK 284731 B6 SK284731 B6 SK 284731B6 SK 142399 A SK142399 A SK 142399A SK 284731 B6 SK284731 B6 SK 284731B6
Authority
SK
Slovakia
Prior art keywords
compound
formula
pharmaceutically acceptable
indazolamide
group
Prior art date
Application number
SK1423-99A
Other languages
English (en)
Slovak (sk)
Other versions
SK142399A3 (en
Inventor
Alessandra Alisi
Mario Brufani
Nicola Cazzolla
Marilena Giannangeli
Mario Pinza
Original Assignee
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. filed Critical Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A.
Publication of SK142399A3 publication Critical patent/SK142399A3/sk
Publication of SK284731B6 publication Critical patent/SK284731B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Paints Or Removers (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
SK1423-99A 1997-04-15 1998-04-02 Indazolamidová zlúčenina, spôsob jej prípravy, medziprodukt na jej prípravu a farmaceutický prostriedok s jej obsahom SK284731B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97MI000867A IT1291569B1 (it) 1997-04-15 1997-04-15 Indazolammidi come agenti serotoninergici
PCT/EP1998/002129 WO1998046589A2 (en) 1997-04-15 1998-04-02 Indazole amide compounds as serotoninergic agents

Publications (2)

Publication Number Publication Date
SK142399A3 SK142399A3 (en) 2000-08-14
SK284731B6 true SK284731B6 (sk) 2005-10-06

Family

ID=11376888

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1423-99A SK284731B6 (sk) 1997-04-15 1998-04-02 Indazolamidová zlúčenina, spôsob jej prípravy, medziprodukt na jej prípravu a farmaceutický prostriedok s jej obsahom

Country Status (27)

Country Link
US (1) US6197769B1 (tr)
EP (1) EP0975623B1 (tr)
JP (2) JP4578581B2 (tr)
KR (1) KR100563867B1 (tr)
CN (1) CN1318416C (tr)
AR (1) AR012426A1 (tr)
AT (1) ATE219490T1 (tr)
AU (1) AU740360B2 (tr)
BG (1) BG64006B1 (tr)
CA (1) CA2286870C (tr)
CZ (1) CZ295190B6 (tr)
DE (1) DE69806141T2 (tr)
DK (1) DK0975623T3 (tr)
EA (1) EA002352B1 (tr)
ES (1) ES2178205T3 (tr)
GE (1) GEP20022654B (tr)
HK (1) HK1027811A1 (tr)
HU (1) HU227973B1 (tr)
IL (1) IL132127A (tr)
IT (1) IT1291569B1 (tr)
PL (1) PL193308B1 (tr)
PT (1) PT975623E (tr)
SK (1) SK284731B6 (tr)
TR (1) TR199902546T2 (tr)
UA (1) UA58550C2 (tr)
WO (1) WO1998046589A2 (tr)
ZA (1) ZA982926B (tr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1291569B1 (it) * 1997-04-15 1999-01-11 Angelini Ricerche Spa Indazolammidi come agenti serotoninergici
DK1379520T3 (da) 2001-02-23 2006-08-21 Merck & Co Inc N-substituerede ikke-aryl-heterocykliske NMDA/NR2B-antagonister
AU2002338334B8 (en) * 2001-04-03 2008-09-18 Merck & Co., Inc. N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B antagonists
ITMI20030287A1 (it) 2003-02-18 2004-08-19 Acraf Indazolammidi dotate di attivita' analgesica metodo, per
ITMI20030972A1 (it) 2003-05-15 2004-11-16 Acraf Indazolo dotato di attivita' analgesica, metodo per prepararlo e composizione farmaceutica che lo comprende.
ITMI20031468A1 (it) * 2003-07-18 2005-01-19 Acraf Farmaco ativo nel dolore neuropatico
TW200533348A (en) * 2004-02-18 2005-10-16 Theravance Inc Indazole-carboxamide compounds as 5-ht4 receptor agonists
US8309575B2 (en) 2004-04-07 2012-11-13 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
TWI351282B (en) * 2004-04-07 2011-11-01 Theravance Inc Quinolinone-carboxamide compounds as 5-ht4 recepto
US7728006B2 (en) * 2004-04-07 2010-06-01 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
WO2006052640A1 (en) * 2004-11-05 2006-05-18 Theravance, Inc. 5-ht4 receptor agonist compounds
EP1807423B1 (en) * 2004-11-05 2009-05-20 Theravance, Inc. Quinolinone-carboxamide compounds
US7419989B2 (en) * 2004-12-22 2008-09-02 Theravance, Inc. Indazole-carboxamide compounds
JP2008530225A (ja) * 2005-02-17 2008-08-07 セラヴァンス， インコーポレーテッド インダゾール−カルボキサミド化合物の結晶型
MX2007010769A (es) * 2005-03-02 2008-03-07 Theravance Inc Compuestos de quinolina como agonistas de receptor 5-ht4.
ITMI20062230A1 (it) * 2006-11-22 2008-05-23 Acraf Composto 2-alchil-indazolico procedimento per preparalo e composizione farmaceutica che lo comprende
UA99927C2 (uk) 2007-11-12 2012-10-25 Ацьенде Кимике Риуните Анджелини Франческо А.Чи.Р.А.Ф. С.П.А. Медикамент, який є активним при невропатичному болі
US8377968B2 (en) 2008-06-02 2013-02-19 Zalicus Pharmaceuticals, Ltd. N-piperidinyl acetamide derivatives as calcium channel blockers
US20140057895A1 (en) * 2011-06-07 2014-02-27 Kazuhiro Mizuno Indazole- and pyrrolopyridine-derivative and pharmaceutical use thereof
SG10201701649YA (en) * 2012-02-21 2017-04-27 Acraf 1h-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta inhibitors
ES2564033T3 (es) * 2012-02-21 2016-03-17 Aziende Chimiche Riunite Angelini Francesco - A.C.R.A.F. - S.P.A. Utilización de compuestos de 1H-indazol-3-carboxamida como inhibidores de la glucógeno sintasa cinasa 3 beta
EP2961403A4 (en) 2013-03-01 2016-11-30 Zalicus Pharmaceuticals Ltd HETEROCYCLIC INHIBITORS OF SODIUM CHANNEL
TW202116314A (zh) 2019-07-11 2021-05-01 美商普雷西斯精密藥品公司 T型鈣離子通道調節劑之調配物及其使用方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9103862D0 (en) * 1991-02-25 1991-04-10 Glaxo Group Ltd Chemical compounds
AU2435092A (en) * 1991-08-20 1993-03-16 Smithkline Beecham Plc 5-ht4 receptor antagonists
IL117438A (en) * 1995-03-16 2001-12-23 Lilly Co Eli Indazolecarboxamides, their preparation and pharmaceutical compositions containing them
KR19990022096A (ko) * 1995-05-31 1999-03-25 쇼다 오사무 모노시클릭 아미노기를 갖는 인다졸 유도체
IT1291569B1 (it) * 1997-04-15 1999-01-11 Angelini Ricerche Spa Indazolammidi come agenti serotoninergici

Also Published As

Publication number Publication date
JP4578581B2 (ja) 2010-11-10
TR199902546T2 (tr) 2000-05-22
ITMI970867A1 (it) 1998-10-15
JP2001518906A (ja) 2001-10-16
EP0975623A2 (en) 2000-02-02
AR012426A1 (es) 2000-10-18
CZ295190B6 (cs) 2005-06-15
KR20010006120A (ko) 2001-01-26
US6197769B1 (en) 2001-03-06
CN1252798A (zh) 2000-05-10
IT1291569B1 (it) 1999-01-11
IL132127A (en) 2005-06-19
ATE219490T1 (de) 2002-07-15
KR100563867B1 (ko) 2006-03-24
DK0975623T3 (da) 2002-10-14
ES2178205T3 (es) 2002-12-16
JP5237324B2 (ja) 2013-07-17
BG64006B1 (bg) 2003-09-30
PL336348A1 (en) 2000-06-19
HK1027811A1 (en) 2001-01-23
PT975623E (pt) 2002-10-31
AU7215998A (en) 1998-11-11
CA2286870A1 (en) 1998-10-22
DE69806141D1 (de) 2002-07-25
CA2286870C (en) 2007-05-22
PL193308B1 (pl) 2007-01-31
EA199900935A1 (ru) 2000-04-24
HUP0002057A2 (hu) 2001-04-28
EA002352B1 (ru) 2002-04-25
AU740360B2 (en) 2001-11-01
CZ362599A3 (cs) 2000-04-12
ZA982926B (en) 1998-10-09
EP0975623B1 (en) 2002-06-19
WO1998046589A3 (en) 1999-01-28
HUP0002057A3 (en) 2002-01-28
HU227973B1 (hu) 2012-07-30
IL132127A0 (en) 2001-03-19
GEP20022654B (en) 2002-03-25
WO1998046589A2 (en) 1998-10-22
SK142399A3 (en) 2000-08-14
DE69806141T2 (de) 2003-01-30
BG103863A (en) 2000-07-31
UA58550C2 (uk) 2003-08-15
JP2010195813A (ja) 2010-09-09
CN1318416C (zh) 2007-05-30

Similar Documents

Publication Publication Date Title
SK284731B6 (sk) Indazolamidová zlúčenina, spôsob jej prípravy, medziprodukt na jej prípravu a farmaceutický prostriedok s jej obsahom
US6900327B2 (en) 4-phenylpiperidine compounds
US5670499A (en) Non-peptide tachykinin receptor antagonists
EP1076055B1 (en) 1- (1-substituted-4-piperidinyl)methyl]-4-piperidine derivatives, process for producing the same, medicinal compositions containing the same and intermediates of these compounds
JP4732354B2 (ja) グリシン輸送阻害薬としての二環式［３．１．０］誘導体
MXPA04010326A (es) Derivados de n-[fenil(piperidin-2-il)metil]benzamida, su preparacion y su aplicacion en terapeutica.
CZ282919B6 (cs) Nové N-alkylenpiperidinové sloučeniny a jejich enantiomery, způsob jejich přípravy a farmaceutické prostředky, které je obsahují
SK281418B6 (sk) Deriváty piperazínu, spôsob ich prípravy, medziprodukt na ich prípravu, ich použitie ako 5ht1a antagonistov a farmaceutický prípravok s ich obsahom
JP2005517723A (ja) 炎症性疾患の治療用ケモカイン受容体阻害剤としてのピペリジン−４−イル尿素誘導体及び関連化合物
JP2013534229A (ja) バニロイド受容体リガンドとしての置換された環状カルボキサミド誘導体および尿素誘導体
KR20010053254A (ko) 무스카린성 길항제
SK141998A3 (en) Piperidines and pyrrolidines
US5260318A (en) Phenylpiperidylamines and drugs containing them
KR100607634B1 (ko) 퀴나졸리논 유도체
FI64364B (fi) Foerfarande foer framstaellning av analgetiskt aktiva n-fenyl-n-(4-piperidinyl)-amidderivat
EP1870396B1 (en) Benzyloxypropylamine derivative
JPWO2005030722A1 (ja) Ｎ−置換−ｎ−（４−ピペリジニル）アミド誘導体
MXPA99009422A (en) Indazole amide compounds as serotoninergic agents

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20150402